2021 annual financial data
Dianthus Therapeutics 2021 Operating cash flow
Dianthus Therapeutics 2021 operating cash flow with verified reported values.
Direct answer
Operating cash flow was -59,531,000 USD.
Operating income was -13,086,000 USD and net income was -13,109,000 USD.
Operating cash flow was -59,531,000 USD.
Get free Dianthus Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,476,000 USD
- Operating income
- -13,086,000 USD
- Net income
- -13,109,000 USD
- Operating cash flow
- -59,531,000 USD